EQT
50
-4
DG
74
-2
ETR
52
-2
ADI
76
-4
EMN
62
-3
EQIX
50
-3
AVGO
38
-25
CHRW
73
-4
DD
55
-4
BMY
74
5
AMP
73
-3
CMI
72
-5
CVS
39
-11
CSCO
60
-4
COST
48
-2
ABT
41
3
D
41
4
AMAT
49
-6
AMG
75
-7
EOG
49
-3
EQT
50
-4
DG
74
-2
ETR
52
-2
ADI
76
-4
EMN
62
-3
EQIX
50
-3
AVGO
38
-25
CHRW
73
-4
DD
55
-4
BMY
74
5
AMP
73
-3
CMI
72
-5
CVS
39
-11
CSCO
60
-4
COST
48
-2
ABT
41
3
D
41
4
AMAT
49
-6
AMG
75
-7
EOG
49
-3
Financhill
Back

Fidelity Disruptive Finance ETF Vs. Nektar Therapeutics Sector Stock Comparison

Buy
78

FDFF
Fidelity Disruptive Finance ETF

Last Price:
$35.70
Seasonality Move:
4.29%
Sell
34

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Buy
78
Fidelity Disruptive Finance ETF (FDFF) is a Buy

Is Fidelity Disruptive Finance ETF a Buy, Sell or Hold?

  • The current Fidelity Disruptive Finance ETF [FDFF] share price is $35.69. The Score for FDFF is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • FDFF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDFF Stock Price Chart

What is Fidelity Disruptive Finance ETF's stock price today?

  • The Fidelity Disruptive Finance ETF share price today is $35.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDFF is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

FDFF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.18 Buy
Relative Strength Index (14 RSI): 59.49 Buy
Chaikin Money Flow: -1515 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.71 - 35.35) Buy
Bollinger Bands (100): (34.84 - 37.72) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

FDFF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.22 Buy
20-day SMA: 34.41 Buy
50-day SMA: 35.07 Buy
200-day SMA: 36.22 Sell
8-day EMA: 35.27 Buy
20-day EMA: 34.89 Buy
50-day EMA: 35.19 Buy
200-day EMA: 35.91 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Fidelity Disruptive Finance ETF Earnings Growth & FDFF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Fidelity Disruptive Finance ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):